Roset M - Search Results

1

Impact of upper digestive symptoms in patients with irritable bowel syndrome.

Balboa A, Mearin F, Badía X, Benavent J, Caballero AM, Domínguez-Muñoz JE, Garrigues V, Piqué JM, Roset M, Cucala M, Figueras M; RITMO Group. Balboa A, et al. Among authors: roset m. Eur J Gastroenterol Hepatol. 2006 Dec;18(12):1271-7. doi: 10.1097/01.meg.0000243870.41207.2f. Eur J Gastroenterol Hepatol. 2006. PMID: 17099375

2

Irritable bowel syndrome subtypes according to bowel habit: revisiting the alternating subtype.

Mearin F, Balboa A, Badía X, Baró E, Caldwell E, Cucala M, Díaz-Rubio M, Fueyo A, Ponce J, Roset M, Talley NJ. Mearin F, et al. Among authors: roset m. Eur J Gastroenterol Hepatol. 2003 Feb;15(2):165-72. doi: 10.1097/00042737-200302000-00010. Eur J Gastroenterol Hepatol. 2003. PMID: 12560761

3

Clinical patterns over time in irritable bowel syndrome: symptom instability and severity variability.

Mearin F, Baró E, Roset M, Badía X, Zárate N, Pérez I. Mearin F, et al. Among authors: roset m. Am J Gastroenterol. 2004 Jan;99(1):113-21. doi: 10.1046/j.1572-0241.2003.04023.x. Am J Gastroenterol. 2004. PMID: 14687152

4

Splitting irritable bowel syndrome: from original Rome to Rome II criteria.

Mearin F, Roset M, Badía X, Balboa A, Baró E, Ponce J, Díaz-Rubio M, Caldwell E, Cucala M, Fueyo A, Talley NJ. Mearin F, et al. Among authors: roset m. Am J Gastroenterol. 2004 Jan;99(1):122-30. doi: 10.1046/j.1572-0241.2003.04024.x. Am J Gastroenterol. 2004. PMID: 14687153

5

Mapping CushingQoL scores onto SF-6D utility values in patients with Cushing's syndrome.

Roset M, Badia X, Forsythe A, Webb SM. Roset M, et al. Patient. 2013;6(2):103-11. doi: 10.1007/s40271-013-0010-7. Patient. 2013. PMID: 23549927 Free PMC article.

6

Mapping AcroQoL scores to EQ-5D to obtain utility values for patients with acromegaly.

Badia X, Trainer P, Biermasz NR, Tiemensma J, Carreño A, Roset M, Forsythe A, Webb SM. Badia X, et al. Among authors: roset m. J Med Econ. 2018 Apr;21(4):382-389. doi: 10.1080/13696998.2017.1419960. Epub 2018 Jan 5. J Med Econ. 2018. PMID: 29261359 Free article.

7

Bayesian regression models for cost-effectiveness analysis.

Polo FJ, Negrín M, Badía X, Roset M. Polo FJ, et al. Among authors: roset m. Eur J Health Econ. 2005 Mar;6(1):45-52. doi: 10.1007/s10198-004-0256-z. Eur J Health Econ. 2005. PMID: 15517461

8

Badía X, Podzamczer D, Moral I, Roset M, Arnaiz JA, Loncà M, Casiró A, Rosón B, Gatell JM; BestQol Study Group. Badía X, et al. Among authors: roset m. Antivir Ther. 2004 Dec;9(6):979-85. Antivir Ther. 2004. PMID: 15651756 Clinical Trial.

9

Validation of a new tool to assess health-related quality of life in psoriasis: the PSO-LIFE questionnaire.

Dauden E, Herrera E, Puig L, Sánchez-Carazo JL, Toribio J, Caloto MT, Nocea G, Roset M, Lara N. Dauden E, et al. Among authors: roset m. Health Qual Life Outcomes. 2012 May 24;10:56. doi: 10.1186/1477-7525-10-56. Health Qual Life Outcomes. 2012. PMID: 22624984 Free PMC article. Clinical Trial.

10

Cost of clinical management of acromegaly in Spain.

Roset M, Merino-Montero S, Luque-Ramírez M, Webb SM, López-Mondéjar P, Salinas I, Soto A, Bernal C, Villabona C, De Luis D, Donnay S, Pascual H, Pérez-Luis J; Spanish group of the OASIS study. Roset M, et al. Clin Drug Investig. 2012 Apr 1;32(4):235-45. doi: 10.2165/11599680-000000000-00000. Clin Drug Investig. 2012. PMID: 22397307

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

100 results

Search Page

Filters